Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overcoming cellular barriers for RNA therapeutics
Steven F. Dowdy
Nature Biotechnology (2017) Vol. 35, Iss. 3, pp. 222-229
Closed Access | Times Cited: 970

Showing 1-25 of 970 citing articles:

The current state and future directions of RNAi-based therapeutics
Ryan L. Setten, John J. Rossi, Si‐ping Han
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 6, pp. 421-446
Closed Access | Times Cited: 1184
Noncoding RNA therapeutics — challenges and potential solutions
Melanie Winkle, Sherien M. El‐Daly, Muller Fabbri, et al.
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 8, pp. 629-651
Open Access | Times Cited: 1142
RNA-Targeted Therapeutics
Stanley T. Crooke, Joseph L. Witztum, C. Frank Bennett, et al.
Cell Metabolism (2018) Vol. 27, Iss. 4, pp. 714-739
Open Access | Times Cited: 685
Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts
Martin P. Stewart, Róbert Langer, Klavs F. Jensen
Chemical Reviews (2018) Vol. 118, Iss. 16, pp. 7409-7531
Open Access | Times Cited: 600
Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking
Daniel E. Murphy, Olivier G. de Jong, Maarten Brouwer, et al.
Experimental & Molecular Medicine (2019) Vol. 51, Iss. 3
Open Access | Times Cited: 589
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
Nico van Zandwijk, Nick Pavlakis, Steven Kao, et al.
The Lancet Oncology (2017) Vol. 18, Iss. 10, pp. 1386-1396
Closed Access | Times Cited: 588
Advances in the delivery of RNA therapeutics: from concept to clinical reality
James C. Kaczmarek, Piotr S. Kowalski, Daniel G. Anderson
Genome Medicine (2017) Vol. 9, Iss. 1
Open Access | Times Cited: 580
Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs
Xiulong Shen, David R. Corey
Nucleic Acids Research (2017) Vol. 46, Iss. 4, pp. 1584-1600
Open Access | Times Cited: 574
Efficient RNA drug delivery using red blood cell extracellular vesicles
Waqas Muhammad Usman, Tin Chanh Pham, Yuk Yan Kwok, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 536
Therapeutic Targeting of Long Non-Coding RNAs in Cancer
Gayatri Arun, Sarah D. Diermeier, David L. Spector
Trends in Molecular Medicine (2018) Vol. 24, Iss. 3, pp. 257-277
Open Access | Times Cited: 529
GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
Aaron D. Springer, Steven F. Dowdy
Nucleic Acid Therapeutics (2018) Vol. 28, Iss. 3, pp. 109-118
Open Access | Times Cited: 527
Endosomal Escape and Delivery of CRISPR/Cas9 Genome Editing Machinery Enabled by Nanoscale Zeolitic Imidazolate Framework
Shahad K. Alsaiari, Sachin Patil, Mram Alyami, et al.
Journal of the American Chemical Society (2017) Vol. 140, Iss. 1, pp. 143-146
Closed Access | Times Cited: 455
Epigenetics and epigenomics in diabetic kidney disease and metabolic memory
Mitsuo Kato, Rama Natarajan
Nature Reviews Nephrology (2019) Vol. 15, Iss. 6, pp. 327-345
Open Access | Times Cited: 450
mRNA-based therapeutics: powerful and versatile tools to combat diseases
Shugang Qin, Xiaoshan Tang, Yu‐Ting Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 426
Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles
Marianna Yanez Arteta, Tomas Kjellman, Stefano Bartesaghi, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 15
Open Access | Times Cited: 420
Polyphenol‐Containing Nanoparticles: Synthesis, Properties, and Therapeutic Delivery
Yuxin Guo, Qing Sun, Fu‐Gen Wu, et al.
Advanced Materials (2021) Vol. 33, Iss. 22
Closed Access | Times Cited: 412
The growth of siRNA-based therapeutics: Updated clinical studies
M. May Zhang, Raman Bahal, Theodore P. Rasmussen, et al.
Biochemical Pharmacology (2021) Vol. 189, pp. 114432-114432
Open Access | Times Cited: 389
Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development
Karishma Dhuri, Clara Bechtold, Elias Quijano, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 6, pp. 2004-2004
Open Access | Times Cited: 388
Nanodelivery of nucleic acids
Bárbara B. Mendes, João Conniot, Aviram Avital, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 388
RNA-based therapeutics: an overview and prospectus
Yiran Zhu, Liyuan Zhu, Xian Wang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 7
Open Access | Times Cited: 384
Multifunctional biomolecule nanostructures for cancer therapy
Jing Wang, Yiye Li, Guangjun Nie
Nature Reviews Materials (2021) Vol. 6, Iss. 9, pp. 766-783
Open Access | Times Cited: 368
RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges
Ai‐Ming Yu, Young Hee Choi, Mei‐Juan Tu
Pharmacological Reviews (2020) Vol. 72, Iss. 4, pp. 862-898
Open Access | Times Cited: 310
The approved gene therapy drugs worldwide: from 1998 to 2019
Cuicui Ma, Zhen-Ling Wang, Ting Xu, et al.
Biotechnology Advances (2019) Vol. 40, pp. 107502-107502
Closed Access | Times Cited: 287
Lipid nanoparticle technology for therapeutic gene regulation in the liver
Dominik Witzigmann, Jayesh A. Kulkarni, Jerry Leung, et al.
Advanced Drug Delivery Reviews (2020) Vol. 159, pp. 344-363
Open Access | Times Cited: 284
RNAi-based therapeutics and tumor targeted delivery in cancer
Göknur Kara, George A. Călin, Bülent Özpolat
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114113-114113
Closed Access | Times Cited: 262
Page 1 - Next Page

Scroll to top